What are the signs of central pontine myelinolysis (CPM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Central Pontine Myelinolysis (CPM)

Central pontine myelinolysis presents with a range of neurological manifestations including spastic quadriparesis, dysarthria, pseudobulbar palsy, and encephalopathy, with severe cases progressing to locked-in syndrome or coma. 1

Clinical Presentation

Motor Symptoms

  • Spastic quadriparesis (tetraparesis) due to damage to descending motor tracts is a hallmark feature 1
  • Pseudobulbar paralysis affecting speech and swallowing functions 1
  • "Locked-in" syndrome in severe cases, characterized by complete paralysis except for vertical eye movements 1, 2
  • Gait abnormalities and frequent falls may be early manifestations 2

Bulbar and Speech Symptoms

  • Dysarthria (difficulty articulating speech) due to involvement of corticobulbar tracts 1
  • Dysphagia (difficulty swallowing) as part of pseudobulbar palsy 1
  • Mutism in advanced cases 3

Cognitive and Psychiatric Manifestations

  • Encephalopathy of varying severity 1
  • Acute psychosis, which can sometimes be the predominant or earliest manifestation 2
  • Personality changes, paranoia, hallucinations, or catatonia may occur, especially when extrapontine areas are involved 2
  • Altered consciousness ranging from confusion to coma 1, 3

Less Common Presentations

  • Cerebellar syndrome with ataxia and coordination difficulties 1
  • Generalized weakness that may precede more specific neurological deficits 2

Risk Factors and Associated Conditions

  • Most commonly associated with rapid correction of hyponatremia (correction exceeding 12 mEq/24h) 1
  • Frequently seen in patients with:
    • Chronic alcoholism 4
    • Malnutrition 4
    • Liver disease 4
    • Prolonged vomiting leading to electrolyte disturbances 3
  • Rarely, can occur with hyperglycemia even with normal sodium levels due to osmotic shifts 5

Diagnostic Features

Imaging Findings

  • Magnetic resonance imaging (MRI) is the imaging procedure of choice 1
  • Characteristic MRI findings include:
    • Area of prolonged T1 and T2 relaxation in the central pons 1
    • Symmetric lesions in the central portion of the base of the pons 1
    • Lesions may have a characteristic "trident" or "bat-wing" shape 6
  • Initial MRI may be unremarkable, with changes becoming apparent on repeat imaging 1-2 weeks later 2

Pathological Features

  • Demyelination affecting the central portion of the base of the pons 1
  • No inflammatory changes are present 1
  • Blood vessels appear normal on pathological examination 1
  • In some cases, similar demyelinating lesions may be found in extrapontine locations (extrapontine myelinolysis) 2, 3

Clinical Course and Prognosis

  • Clinical deterioration often follows correction of electrolyte abnormalities 3
  • Recovery is variable, ranging from no improvement to substantial recovery 1
  • Prevention is critical by limiting correction of serum sodium to no more than 12 mEq/24h in hyponatremic patients 1

Important Considerations

  • CPM can occur even when sodium correction rates are within recommended limits 1
  • Neuropsychiatric symptoms may predominate in early stages, before classic motor symptoms develop 2
  • Extrapontine involvement can occur and may contribute to the clinical presentation 2, 3
  • CPM should be considered in patients with acute neurological deterioration following correction of electrolyte abnormalities, particularly hyponatremia 1, 3

References

Research

Central pontine myelinolysis.

Mayo Clinic proceedings, 2001

Research

Acute Psychosis as Main Manifestation of Central Pontine Myelinolysis.

Case reports in neurological medicine, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.